mci 9038 has been researched along with Heart Arrest in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Daniels, LM; Sagardia, LM | 1 |
Ascaso, M; Pereda, D; Quintana, E; Sandoval, E | 1 |
2 other study(ies) available for mci 9038 and Heart Arrest
Article | Year |
---|---|
Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19.
Topics: Adult; Anticoagulants; Arginine; Coronavirus Infections; COVID-19; Fibrinolytic Agents; Heart Arrest; Heparin, Low-Molecular-Weight; Humans; Male; Pandemics; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; Sulfonamides; Thrombolytic Therapy; Treatment Failure; Treatment Outcome | 2020 |
An infrequent complication of a not so infrequent disease. Hit by HIT.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Antithrombins; Aortic Valve; Arginine; Drug Substitution; Echocardiography, Transesophageal; Electrocardiography; Extracorporeal Membrane Oxygenation; Fatal Outcome; Heart Arrest; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Heparin; Humans; Male; Pipecolic Acids; Sulfonamides; Thrombectomy; Thrombocytopenia; Thrombosis; Treatment Outcome | 2019 |